SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTialis Essen It Regulatory News (TIA)

Share Price Information for Tialis Essen It (TIA)

Share Price is delayed by 15 minutes
Get Live Data
50.50    0.00 (0.00%)
Bid:
50.00
Ask:
51.00
Spread: 1.00 (2.00%)
Market Cap: £20.15m
TIA Live PriceLast checked at - London Stock Exchange

Intraday Tialis Essen It Share Chart

Trading Update

6 Jan 2025 07:00

RNS Number : 1458S
Tialis Essential IT PLC
06 January 2025
 

 

 

Tialis Essential IT Plc

 

("Tialis" or the "Company")

 

06 January 2025

Trading Update for the year ended 31 December 2024

 

 

Tialis, the mid-market IT Managed Services provider, gives an update on trading for the year ended 31 December 2024.

 

Financial Highlights

 

· Revenue for the year is expected to be no less than £20.5m

 

· Tialis has had a third consecutive year of Adjusted EBITDA1 of no less than £2m

 

· Significant year on year increase in positive cash generation

 

· Tialis agreed a £4m Revolving Credit Facility ("RCF") with Santander. The RCF carries an interest rate of SONIA + 3.75 per cent. and is for a term of 3 years. The RCF was used for early repayment of the loan notes of £4.2m which were due for repayment in January and December 2025.

 

· Current sales pipeline is £11m with a record number of 19 different partners

 

· 2025 revenue is expected to be made up of 48% contracted revenue, 29% anticipated contract extensions, and 23% new business

 

 

Ian Smith, Executive Director, commented:

"The board is committed to growing Tialis both from M&A activities and organic sales, and we collectively intend the group to become a cash generating vehicle and will look to implement a progressive dividend policy in the future. The recent acquisition of shares from an existing institution is testament to our commitment, which only adds to the substantial shareholding between Daisy/Matt and MXC/Ian. Despite recent proposed changes to the IHT legislation we believe that trading AIM equities retain their IHT attractiveness".

 

 

For more information, contact:

 

Tialis Essential IT Plc

Ian Smith, Executive Director

 

Tel: +44 (0)344 874 1000

Cavendish Capital Markets Ltd

Nominated Adviser and Broker

Corporate finance: Jonny Franklin-Adams/ Elysia Bough

Corporate Broking: Tim Redfern

 

Tel: +44 (0)20 7220 0500

Notes:

1 Adjusted EBITDA excludes share-based payment charges along with depreciation, amortisation, interest, and tax from the measure of profit.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSSUFWDEISELF
12
Date   Source Headline
23rd Aug 20233:54 pmRNSDirector Dealing
22nd Aug 20233:32 pmRNSDirector Dealing
21st Aug 20234:57 pmRNSDirector Dealing
7th Aug 20237:00 amRNSUnaudited Interim Results
26th Jul 20237:00 amRNSTrading Update
30th Jun 20239:35 amRNSHolding(s) in Company
30th Jun 20239:35 amRNSHolding(s) in Company
28th Jun 202312:54 pmRNSResult of Annual General Meeting
1st Jun 20237:00 amRNSIssue of Equity
9th May 20237:00 amRNSFinal Results
25th Apr 20237:00 amRNSNotice of Results
8th Feb 20237:00 amRNSDirectorate Change
3rd Feb 20232:31 pmRNSHolding(s) in Company
3rd Feb 20232:31 pmRNSHolding(s) in Company
1st Feb 20238:00 amRNSCompletion of Acquisition
4th Jan 20237:00 amRNSDirectorate Change
23rd Dec 202210:21 amRNSDirector/PDMR Shareholding
22nd Dec 202210:23 amRNSDirector/PDMR Shareholding
21st Dec 20223:09 pmRNSDirector/PDMR Shareholding
20th Dec 20227:00 amRNSAcquisition
22nd Nov 20227:00 amRNSIssue of Equity
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.